LEAP THERAPEUTICS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Leap Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • Leap Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$18.2M, a 32.7% decline year-over-year.
  • Leap Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$64.6M, a 20.3% increase year-over-year.
  • Leap Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$81.4M, a 49.1% decline from 2022.
  • Leap Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$54.6M, a 34.5% decline from 2021.
  • Leap Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$40.6M, a 47.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$81.4M -$26.8M -49.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$54.6M -$14M -34.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$40.6M -$13.1M -47.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 -$27.5M +$5.39M +16.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 -$32.9M -$9.76M -42.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$23.1M +$6.59M +22.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$29.7M -$4.1M -16% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$25.6M Jan 1, 2016 Dec 31, 2016 10-K 2018-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.